Pyrethon Suspension contains Pyrimethamine 12.5mg + Sulphadoxine 250mg, a fixed-dose antimalarial combination indicated for the treatment and prophylaxis of Plasmodium falciparum and other susceptible malaria infections. It helps in clearing blood-stage parasites and preventing disease recurrence.
Pyrimethamine inhibits folate metabolism in the malaria parasite, while Sulphadoxine acts as a synergistic antimicrobial, enhancing parasite clearance. The combination ensures high efficacy, rapid symptom resolution, and reduced risk of resistance.
For distributors and healthcare suppliers, Pyrethon Suspension is a high-demand antimalarial product, widely used in hospitals, pediatric clinics, endemic regions, and public health malaria control programs. Seasonal malaria incidence and preventive health measures contribute to consistent demand.
Adding Pyrethon Suspension to your antimalarial therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, prescriber trust, and essential role in malaria management make it a valuable addition to pharmaceutical distribution portfolios.